EY
Fraud Investigation & Dispute Services, Life Sciences team

Tighter competition, regulatory scrutiny and tough enforcement heighten the risk of litigation and non-compliance. In your industry, compliance issues and risk factors need to be addressed at every turn from research and development to marketing strategies and supply chain integrity. And the scrutiny of regulators and customers alike is increasing and rapidly changing. Focused on your industry. Our professionals understand the complex issues facing pharmaceutical, biotechnology and medical device companies. We have established experience helping companies evaluate and manage those aspects of their businesses that pose the greatest potential risks. Our dedicated team includes CPAs, government contract analysts, economists, licensed pharmacists and certified fraud examiners, as well as former pharmaceutical executives, ethics and compliance officers and government auditors, investigators and prosecutors.

For more information visit http://www.ey.com/us/fids or contact Ted Acosta, Principal, EY Fraud Investigation & Dispute Services, Life Sciences Leader, (212) 773-3022.

PwC
PwC's Pharmaceutical and Life Sciences Industry Group is dedicated to delivering effective solutions to the complex strategic, operational and financial challenges facing pharmaceutical, biotechnology and medical device companies. We provide industry-focused assurance, tax and advisory services to build public trust and enhance value for our clients and their stakeholders. More than 180,000 people in 158 countries across our network share their thinking, experience and solutions to develop fresh perspectives and practical advice. For more information visit www.pwc.com/pharma and www.pwc.com/medtech, contact Marina Bello Valcarce, +44 207 212 8642.

AHM
AHM is a leading provider of HCP Interaction and Compliance Solutions to the Global Life Sciences Industry. Our technology and service solutions are used by tens of thousands of industry sales representatives, managers and healthcare professionals worldwide. For more information visit www.ahmdirect.com or contact Wayne Baker, Sr. Vice President & Chief Sales Officer, (908) 393-8820.

Arnold & Porter
Arnold & Porter LLP, an 800 lawyer firm with offices in the US and Europe, is ideally positioned to serve the needs of the international biopharmaceutical and medical device community. Our team of more than 50 regulatory and compliance attorneys counsel life sciences companies at all stages of the product life cycle. We regularly advise companies in matters raising complex compliance issues, developing practical solutions to the challenges associated with conducting global clinical trials in jurisdictions with varying healthcare systems; the complexities and risks of pharmaceutical supply chains; interactions with physician and patient populations; managing co-development and co-promotion arrangements; and outsourcing of functions in areas such as research, pharmacovigilance, and manufacturing, and vigorously defend our clients in a broad range of investigations and enforcement matters.

For more information please visit www.arnoldporter.com or contact Daniel A. Kracov, Partner, +1 202-942-5120.

Baker & McKenzie
Baker & McKenzie's involvement in the pharmaceutical, healthcare and medical industry stretches over 50 years. During this time, our lawyers have developed a depth of knowledge in the industry in respect of various market players including manufacturers, distributors, research institutions, clinical trial bases and health and regulatory authorities. In addition to our lawyers within the Asia Pacific region, the team includes registered pharmacists and electrical and mechanical engineers.

Baker & McKenzie has a legal network spanning 74 locations in 46 countries. With our expansive global footprint the pharmaceutical, healthcare and medical group has a strong understanding of the changing regulations regarding product registration, market access, trade promotion, product liability, labeling and advertising restrictions and other issues that affect market players in the developing Asian market.

For more information, please visit www.bakermckenzie.com, or contact Peerapan Tungsuwan, Chair Asia Pacific Pharmaceuticals & Healthcare Industry Group, +66 2 636 2000 ext. 4334.

Cegedim
Cegedim Relationship Management is the Life Sciences industry's leading provider of Customer Relationship Management (CRM) and Business Compliance solutions in more than 80 countries. Given the recent enactment of diverse regulatory and disclosure regulations across every market, the pharmaceutical industry is focused on mitigating reputational risks, fines and possible court cases associated with bribery and corruption. However, achieving compliance monitoring and reporting becomes a complex challenge, not to mention costly.

AggregateSpend 360 is a web-based application that streamlines the tracking, consolidation, auditing and reporting of all expenditures between sales force and physicians following global anti-bribery regulations (UK Bribery Act, U.S. Foreign Corrupt Practices Act). In addition to that, Cegedim commits to providing all reporting and disclosure templates required by local authorities based on existing Transparency requirements (JPMA in Japan, U.S. Federal and state laws, French Sunshine Act, etc…). This process can be leveraged by an accurate customer data management and the integration of a wide range of enterprise applications -- CRM, ERP, Finance and Travel&Expenses - for in-depth analysis and improved insight.

For more information, please visit www.CegedimRM.com.

Davis Wright Tremaine
Those of us in the Davis Wright Tremaine health care practice group devote nearly all of our time to industry-specific matters. This allows us to develop niche practices within the field that serve needs unique to the health care market. We also understand the business issues and regulatory developments that affect health care delivery and compliance, and as a unified team we can match the attorney with the niche expertise that best addresses client needs. For more information visit our website at www.DWT.com.

Porzio Life Sciences, LLC
Porzio Life Sciences, LLC (PorzioLS) provides the life science industry with Internet-based products enabling companies to comply with marketing and sales federal and state laws and regulations, as well as, distribution, licensing, sampling and a growing body of state life science compliance requirements. PorzioLS provides compliance tools and customized services, related to the PDMA, anti-kickback statutes, aggregate spend reporting, OIG and CMS guidances, False Claims Act and FDA regulations, such as the Porzio Compliance Digest and Porzio AggregateSpendID, a best in class aggregate spend system capable of handling state and federal transparency reporting, in addition to sample transparency reporting. Porzio AggregateSpendID streamlines state and federal marketing disclosures by automating the collection and accurate reporting of expenses directed to healthcare practitioners and organizations. The searchable databases of the Porzio Compliance Digest cover drug and device licensing and distribution, transparency legislation, sample and trade product distribution, and trends in government investigations. Through our Distribution Licensing Services, we identify and attain all required licenses based on a company's unique distribution model. Finally, our formula-based approach to sample accountability, Significant Loss Threshold Assurance, ensures that customers neither over or under report sample losses. These compliance tools and customized services facilitate companies' compliance with federal and state marketing and sales regulations, which has propelled PorzioLS into an industry leader in life science marketing and sales compliance. Strengthen your compliance program today by visiting www.porziolifesciences.com or contacting us 877-477-7411.

Sidley Austin
Sidley Austin LLP is a premier law firm with an internationally recognized life sciences practice, representing major pharmaceutical, biotechnology, medical device, diagnostics, dietary supplements and food clients. Sidley consistently ranks among the top firms in Asia, Europe and the U.S. and many lawyers on our team are acknowledged leaders in their field. Sidley was the first international law firm to establish a stand-alone, comprehensive food and drug regulatory practice in China. We were ranked Tier I in Life Sciences in China by Chambers Asia Pacific since the category was launched in 2009. With more 30 years experience and six offices in Asia, our lawyers advise life sciences clients in every aspect of their business operations, including regulatory and compliance, corporate and M&A, government enforcement, FCPA, antitrust and others. For more information visit www.Sidley.com or contact Chen Yang at 86-10-5905 5600 or Yuet Ming Tham at 852-2509 7645.

Seton Hall Law
Seton Hall Law's Center for Health & Pharmaceutical Law & Policy advances scholarship and recommendations for policy on the varied and complex issues posed by health and pharmaceutical law. As a nationally ranked Health Law program, the Center fosters informed dialogue between policymakers, consumer advocates, the medical profession, and industry in the search for solutions to the ethical, legal and social questions presented in the health and pharmaceutical arena.

In addition, the Center is a leader in providing healthcare compliance education and training in the U.S., and Europe and Asia-Pacific on national and international mandates that apply to the safety and promotion of drugs and devices. The Center also hosts conferences and educational programs, inviting leading experts from the public and private sectors to examine cutting edge policy issues.

Launched in April 2007, the Center extends Seton Hall Law School's national reputation in health law to the life sciences arena and offers a challenging health law curriculum through its M.S.J., J.D. and LL.M. degree programs, and online Graduate Certificates, and online M.S.J. The Center operates under the leadership of a full-time Executive Director, Simone Handler-Hutchinson, and draws upon the intellectual strength of the Seton Hall Law School faculty and research fellows who bring to the Center's work nationally recognized expertise in health and pharmaceutical law, not-for-profit governance, intellectual property law and bioethics, among other areas.

For further information or inquiries about the Center and its varied programs, please visit the website at law.shu.edu/CenterforHealth and law.shu.edu/compliance, or contact Simone Handler-Hutchinson, Executive Director of the Center.